The following is a summary of “Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients,” published in the May 2025 issue of British Journal of Hematology by Bouchla et al.
The post Luspatercept-Induced Transfusion Independence in LR-MDS first appeared on Physician’s Weekly.
